| Literature DB >> 28355568 |
Jing Zhou1, An-Chi Tien2, John A Alberta1, Scott B Ficarro3, Amelie Griveau2, Yu Sun1, Janhavee S Deshpande4, Joseph D Card4, Meghan Morgan-Smith5, Wojciech Michowski6, Rintaro Hashizume7, C David James7, Keith L Ligon8, William D Snider5, Peter Sicinski6, Jarrod A Marto9, David H Rowitch10, Charles D Stiles11.
Abstract
During development of the vertebrate CNS, the basic helix-loop-helix (bHLH) transcription factor Olig2 sustains replication competence of progenitor cells that give rise to neurons and oligodendrocytes. A pathological counterpart of this developmental function is seen in human glioma, wherein Olig2 is required for maintenance of stem-like cells that drive tumor growth. The mitogenic/gliomagenic functions of Olig2 are regulated by phosphorylation of a triple serine motif (S10, S13, and S14) in the amino terminus. Here, we identify a set of three serine/threonine protein kinases (glycogen synthase kinase 3α/β [GSK3α/β], casein kinase 2 [CK2], and cyclin-dependent kinases 1/2 [CDK1/2]) that are, collectively, both necessary and sufficient to phosphorylate the triple serine motif. We show that phosphorylation of the motif itself serves as a template to prime phosphorylation of additional serines and creates a highly charged "acid blob" in the amino terminus of Olig2. Finally, we show that small molecule inhibitors of this forward-feeding phosphorylation cascade have potential as glioma therapeutics.Entities:
Keywords: CDK; CK2; GSK3; NPCs; Olig2; casein kinase 2; cyclin-dependent kinase; glioma; glycogen synthase kinase 3; neural progenitor cells; phosphorylation; protein kinase
Mesh:
Substances:
Year: 2017 PMID: 28355568 PMCID: PMC5394178 DOI: 10.1016/j.celrep.2017.03.003
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423